• Mashup Score: 0

    for all children <18 years who underwent GJT placement to treat GERD. We collected data at the first GJT placement, 5 months after last GJT withdrawal, and at the end of the follow-up (June 2021). Results: Among 46 GERD patients with 86 GJT, 32 (69.6%) and 30 (65.2%) avoided antireflux surgery 5 and 28 months, respectively, after the definitive GJT removal. Five months after GJT removal, discharge from hospital, transition to gastric nutrition, GERD complications, and treatment were significantly improved. Median age and weight at the first GJT placement were 7 months and 6.8 kg. Patients had digestive comorbidities or complicated GERD in 69.6% and 76.1% patients, respectively. The median duration of jejunal nutrition using GJT was 64.5 days. GJT had to be removed in 63 (75.9%) cases for technical problems. Conclusions: Jejunal nutrition by GJT could be an alternative to antireflux surgery avoiding sustainably antireflux surgery in most of complicated GERD patients. The high frequency

    Tweet Tweets with this article
    • Faccioli et al retrospectively reviewed the impact of gastrojejunal tube (GJT) feeding in #children with refractory #GERD. 👉 65% avoided anti-reflux surgery 👉 duration of jejunal feeding was short with only 1-2 GJT placements for most https://t.co/1AMxdn0AcP https://t.co/fq5K178gr6

  • Mashup Score: 1

    In 2020, Analatos and colleagues published the results of a randomized, double-blind, clinical trial1 comparing tension-free mesh vs suture-alone cruroplasty in antireflux surgery. A total of 159 patients with symptomatic gastroesophageal reflux disease and a hiatal hernia were enrolled and randomly…

    Tweet Tweets with this article
    • Mesh and Hiatal Hernia Repair—The Never-Ending Saga | Surgery | #gerd #foregut #reflux ⁦@JAMASurgery⁩ | @JAMANetwork https://t.co/B9GTEgObHU

  • Mashup Score: 22

    The Lyon Consensus provides conclusive criteria for and against the diagnosis of gastro-oesophageal reflux disease (GERD), and adjunctive metrics that consolidate or refute GERD diagnosis when primary criteria are borderline or inconclusive. An international core and working group was assembled to evaluate research since publication of the original Lyon Consensus, and to vote on statements collaboratively developed to update criteria. The Lyon Consensus 2.0 provides a modern definition of actionable GERD, where evidence from oesophageal testing supports revising, escalating or personalising GERD management for the symptomatic patient. Symptoms that have a high versus low likelihood of relationship to reflux episodes are described. Unproven versus proven GERD define diagnostic strategies and testing options. Patients with no prior GERD evidence (unproven GERD) are studied using prolonged wireless pH monitoring or catheter-based pH or pH-monitoring off antisecretory medication, while pat

    Tweet Tweets with this article
    • RT @AndrewOngML: https://t.co/bZmEh1ULKj Timely update to Lyon Consensus for #GERD, now version 2 Interesting updates - re-look at GERD d…

  • Mashup Score: 0

    Shared genetics may underlie the common observation that patients with gastroesophageal reflux disease commonly have anxiety or depressive symptoms, and vice versa, an analysis suggests.

    Tweet Tweets with this article
    • #Anxiety and #depression are prevalent in patients with gastroesophageal reflux disease, according to a large-scale analysis that also found evidence for a possible underlying causal link between #GERD and common psychiatric conditions. #MedTwitter https://t.co/83IzBJoc7a

  • Mashup Score: 0
    Home - 8 month(s) ago

    Gastroesophageal reflux disease (GERD) is a chronic, highly prevalent gastrointestinal disorder, and one of the most common complaints seen in primary care. Proton pump inhibitors (PPIs) are the mainstay of medical treatment of GERD and its more serious form, erosive esophagitis. However, some patients do not have an adequate response to these drugs and symptom recurrence is common. With new acid suppressing therapies on the horizon, physicians may soon have more options for treating GERD. In this live,

    Tweet Tweets with this article
    • Join our experts October 28, 2023, as they discuss 📊 evidence-based treatments for #GERD. Secure your 🪑 by clicking here: https://t.co/aGOgru9cSn https://t.co/A0RutSIt1l

  • Mashup Score: 9

    Do you know how to manage patients with gastroesophageal reflux disease (GERD)/erosive esophagitis (EE) who do not respond to proton pump inhibitor (PPI) therapy?

    Tweet Tweets with this article
    • ➡️ Do you know how to manage patients with gastroesophageal reflux disease/erosive esophagitis who do not respond to proton pump inhibitor therapy? #GERD 📍 https://t.co/fCjk9mumMV https://t.co/N9SYxlgjrm

  • Mashup Score: 7

    The AI chatbot provided largely appropriate responses and at least some specific guidance for GERD management, although inconsistencies and content errors require clinical oversight, researchers say.

    Tweet Tweets with this article
    • The artificial intelligence chatbot ChatGPT can potentially be used as source of information for patients, as well as an aid to clinicians managing #GERD, a study has found. #GastroTwitter https://t.co/DVfolFUidK

  • Mashup Score: 0
    AGA University - 11 month(s) ago

    NPs and PAs are increasingly called upon to provide patient-centered, high-value care in various GI practice settings. They may handle multiple parts of patient care, from outpatient settings to inpatient settings, caring for patients with acute illnesses, diagnosing and managing chronic GI and liver diseases, and in some case, performing screening colonoscopies and flexible sigmoidoscopies. The…

    Tweet Tweets with this article
    • Register now for the 2023 Principles of GI for the NP and PA and receive expert guidance on diagnosing and treating dysphagia, #GERD, eosinophilic disorders, #IBS, cirrhosis and more. Register now and save up to $200 through June 29. @GregSayuk https://t.co/aBB3sUz5Qp https://t.co/gLBU90uKX8